Journal of Oleo Science
Online ISSN : 1347-3352
Print ISSN : 1345-8957
ISSN-L : 1345-8957
Essential Oils and Natural Products
Evaluation of Bauhinia ungulata Essential Oil as a New Acetylcholinesterase Inhibitor from an in silico and in vitro Perspective in the Northern Amazon of Brazil
Sandra Regina Nunes de Andrade MedeirosIverson Conrado BezerraLucas Aleixo Leal PedrozaArtur José da SilvaRegildo Max Gomes MartinsThaís Meira MenezesAna Cristina Gonçalves Reis de MeloJorge L. NevesPriscila GubertAntonio Alves de Melo Filho
Author information
JOURNAL OPEN ACCESS
Supplementary material

2024 Volume 73 Issue 8 Pages 1091-1104

Details
Abstract

The Bauhinia ungulata, also known by its common name “pata de vaca”, is one of the species used in Brazil for medicinal purposes, and is commonly used for the treatment of diabetes. In this study, the authors studied the interaction between the chemical constituents which are present in the essential oil of Bauhinia ungulata (EOBU), collected in Boa Vista-RR, Legal Amazon, and their effects on the enzyme acetylcholinesterase (AChE) in the essential oil. The analysis that we perform includes proton magnetic resonance ( 1H NMR), enzymatic inhibition, molecular docking, in silico toxicity prediction, enrichment analysis, and target prediction for biological interactions. According to the tests performed on the essential oil, it obtained 100% inhibition of the enzyme AChE. During 1H NMR experiments, it was found that α- Bisabolol, one of the main components, had a significant alteration in its chemical shift. A molecular docking analysis confirmed that this compound binds to the AChE enzyme, which confirms the 1H NMR analysis. The results of this work showed that the major component of EOBU acted as a possible inhibitor of AChE enzyme in vitro and in silico assays. These results show that EOBU could be potentially applied in Alzheimer’s disease treatment.

graphical abstract Fullsize Image
Content from these authors
© 2024 by Japan Oil Chemists' Society

This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/
Previous article Next article
feedback
Top